Our clients
We support our clients in their business affairs and offer tailor-made solutions with a special focus on the medical-pharmaceutical sector. Some clients do not want to be identified by name. If you are interested to hear more details about our services, please contact me personally.
Project examples
![](https://jmc-finanz.ch/cms/assets/uploads/2021/02/JMC_Icons_auge-1-400x390.jpg)
Private bond to finance innovative medical laser technology
Rowiak GmbH supports ophthalmologists and opticians with ultra-precise lasers and highly sensitive opto-electronics. The high-tech company needed fresh capital to certify and launch a new laser system for the treatment of presbyopia.
JMA successfully placed a private bond for 3 million euros to finance this project. The interest rate was fixed at 7.9%, rising to 9.9% after successful completion of the clinical trials.
![](https://jmc-finanz.ch/cms/assets/uploads/2021/02/JMC_Icons_medikament-400x390.jpg)
Financing a clinical trial for a drug to enhance blood circulation
A StartUp in Switzerland is developing new microvascular therapies that can be used to treat cardiovascular diseases and cerebrovascular disorders. Capital was needed to fund a clinical trial to establish the use of a new drug for brain haemorrhages.
JMC successfully recruited suitable investors, Günter Jucho was appointed to the Board of Directors and is performing the operational position of CFO.
![](https://jmc-finanz.ch/cms/assets/uploads/2021/02/JMC_Icons_studie-400x390.jpg)
Commercial support to finance a clinical trial for treatment of obesity
Aphaia Pharma is a pharmaceutical company that develops treatments for this metabolic syndrome. The aim is to combat obesity, type 2 diabetes, fatty liver and heart disease, among other ailments. JMC is a shareholder and Günter Jucho is a member of the Board of Directors.